Screener
Cullinan Therapeutics, Inc. CGEM Invested capital
Discontinued — last reported Q4 '25
Invested capital at other companies
Other financials
Where this comes from
Calculated from Cullinan Therapeutics, Inc.’s reported figures.
The source filing: Cullinan Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336717
FAQ
- What is Cullinan Therapeutics, Inc.'s invested capital?
- Cullinan Therapeutics, Inc. (CGEM) reported invested capital of $323.08M in Q4 2025.
- How has Cullinan Therapeutics, Inc.'s invested capital changed year-over-year?
- Cullinan Therapeutics, Inc.'s invested capital decreased by 36.6% year-over-year, from $509.47M to $323.08M.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s invested capital?
- Over 4 years (2021 to 2025), Cullinan Therapeutics, Inc.'s invested capital has grown at a -3.1% compound annual growth rate (CAGR), from $366.57M to $323.08M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Cullinan Therapeutics, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude